60 Degrees Pharmaceuticals (SXTP) Return on Capital Employed (2023 - 2025)
Historic Return on Capital Employed for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to 2.44%.
- 60 Degrees Pharmaceuticals' Return on Capital Employed fell 3500.0% to 2.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.44%, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of 1.9% for FY2024, which is 11200.0% up from last year.
- As of Q3 2025, 60 Degrees Pharmaceuticals' Return on Capital Employed stood at 2.44%, which was down 3500.0% from 2.27% recorded in Q2 2025.
- In the past 5 years, 60 Degrees Pharmaceuticals' Return on Capital Employed registered a high of 0.68% during Q3 2023, and its lowest value of 2.53% during Q1 2025.
- In the last 3 years, 60 Degrees Pharmaceuticals' Return on Capital Employed had a median value of 1.97% in 2024 and averaged 1.72%.
- Examining YoY changes over the last 5 years, 60 Degrees Pharmaceuticals' Return on Capital Employed showed a top increase of -3500bps in 2025 and a maximum decrease of -17300bps in 2025.
- Over the past 3 years, 60 Degrees Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.92% in 2023, then tumbled by -115bps to 1.97% in 2024, then dropped by -24bps to 2.44% in 2025.
- Its Return on Capital Employed was 2.44% in Q3 2025, compared to 2.27% in Q2 2025 and 2.53% in Q1 2025.